• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊髓液和唾液中的乳铁蛋白不是混合记忆门诊人群阿尔茨海默病的诊断生物标志物。

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population.

机构信息

Department of Neurology, Danish Dementia Research Centre (DDRC), Copenhagen University Hospital, Rigshospitalet, Denmark.

Department of Neurology, Danish Dementia Research Centre (DDRC), Copenhagen University Hospital, Rigshospitalet, Denmark.

出版信息

EBioMedicine. 2021 May;67:103361. doi: 10.1016/j.ebiom.2021.103361. Epub 2021 May 8.

DOI:10.1016/j.ebiom.2021.103361
PMID:33975253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8122152/
Abstract

BACKGROUND

The pathological changes in Alzheimer's Disease (AD) and other neurodegenerative disorders begin decades prior to their clinical expression. However, the clinical diagnosis of neurodegenerative dementias is not straightforward. Lactoferrin is an iron-binding, antimicrobial glycoprotein with a plethora of functions, including acting as an important immune modulator and by having a bacteriocidic effect. Two previous studies indicated that salivary lactoferrin could differentiate between neurodegenerative dementias.

METHODS

A total of 222 cerebrospinal fluid (CSF) and saliva samples from a consecutive, mixed memory clinic population were analysed for lactoferrin. In addition, the association between lactoferrin in CSF and saliva and the concentration of tau, phosphorylated tau (p-tau) and amyloid 1-42 (Aβ) in CSF were addressed.

FINDINGS

CSF lactoferrin was assessed for the first time in a cohort of patients with neurodegenerative dementias. No significant differences were found in the levels of CSF or saliva lactoferrin between the diagnostic groups. In addition, no significant relationships were found between lactoferrin levels and tau, p-tau and Aβ, respectively.

INTERPRETATION

Neither CSF nor saliva lactoferrin could differentiate between neurodegenerative dementias in this study.

摘要

背景

阿尔茨海默病(AD)和其他神经退行性疾病的病理变化早在其临床表达前几十年就开始了。然而,神经退行性痴呆症的临床诊断并不简单。乳铁蛋白是一种含铁的、抗菌糖蛋白,具有多种功能,包括作为重要的免疫调节剂和具有杀菌作用。之前的两项研究表明,唾液乳铁蛋白可以区分神经退行性痴呆症。

方法

对连续的混合记忆诊所人群的 222 份脑脊液 (CSF) 和唾液样本进行了乳铁蛋白分析。此外,还研究了 CSF 和唾液中乳铁蛋白与 CSF 中 tau、磷酸化 tau (p-tau) 和淀粉样蛋白 1-42 (Aβ) 浓度之间的关联。

结果

首次在神经退行性痴呆症患者队列中评估 CSF 乳铁蛋白。在诊断组之间,CSF 或唾液乳铁蛋白水平没有差异。此外,乳铁蛋白水平与 tau、p-tau 和 Aβ 之间也没有显著关系。

结论

在本研究中,CSF 和唾液乳铁蛋白均不能区分神经退行性痴呆症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7a/8122152/c5428fd3afe2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7a/8122152/1a25076debc5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7a/8122152/c5428fd3afe2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7a/8122152/1a25076debc5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7a/8122152/c5428fd3afe2/gr2.jpg

相似文献

1
Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population.脑脊髓液和唾液中的乳铁蛋白不是混合记忆门诊人群阿尔茨海默病的诊断生物标志物。
EBioMedicine. 2021 May;67:103361. doi: 10.1016/j.ebiom.2021.103361. Epub 2021 May 8.
2
Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases.神经退行性疾病中的脑脊液和血浆生物标志物。
J Alzheimers Dis. 2019;68(1):395-404. doi: 10.3233/JAD-181152.
3
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
4
Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.脑脊液中生物标志物用于阿尔茨海默病的成本效益分析
J Alzheimers Dis. 2014;42(3):777-88. doi: 10.3233/JAD-132216.
5
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease.类视黄醇蛋白-1:阿尔茨海默病的诊断和预后生物标志物。
Ann Neurol. 2011 Aug;70(2):274-85. doi: 10.1002/ana.22448.
6
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.在OPTIMA队列中,脑脊液生物标志物可将经尸检确诊的阿尔茨海默病与其他痴呆症及健康对照区分开来。
J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725.
7
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
8
Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.脑脊液生物标志物(磷酸化tau181、总tau、Aβ42 和 Aβ40)在阿尔茨海默病和路易体痴呆前驱期的诊断价值。
J Alzheimers Dis. 2016;51(4):1069-83. doi: 10.3233/JAD-150731.
9
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
10
Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.泰国诗里拉吉医院对阿尔茨海默病(AD)及其他痴呆症患者的脑脊液(CSF)β-淀粉样蛋白(1-42)、磷酸化tau蛋白(ptau-181)和总tau蛋白进行评估。
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.

引用本文的文献

1
Salivary lactoferrin levels in Down Syndrome: a case-control study.唐氏综合征患者唾液乳铁蛋白水平:一项病例对照研究。
Brain Behav Immun Health. 2025 Apr 21;46:100999. doi: 10.1016/j.bbih.2025.100999. eCollection 2025 Jul.
2
Lactoferrin as a Candidate Multifunctional Therapeutic in Synucleinopathies.乳铁蛋白作为突触核蛋白病的多功能候选治疗药物。
Brain Sci. 2025 Apr 6;15(4):380. doi: 10.3390/brainsci15040380.
3
Differences in Plasma Lactoferrin Concentrations Between Subjects with Normal Cognitive Function and Mild Cognitive Impairment: An Observational Study.
认知功能正常与轻度认知障碍受试者血浆乳铁蛋白浓度的差异:一项观察性研究。
Healthcare (Basel). 2025 Apr 11;13(8):872. doi: 10.3390/healthcare13080872.
4
An Update of Salivary Biomarkers for the Diagnosis of Alzheimer's Disease.用于阿尔茨海默病诊断的唾液生物标志物最新进展
Int J Mol Sci. 2025 Feb 26;26(5):2059. doi: 10.3390/ijms26052059.
5
Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.阿尔茨海默病研究中唾液生物标志物研究的分析前变量标准化指南:痴呆研究唾液生物标志物工作组的最新综述与共识
Alzheimers Dement. 2025 Feb;21(2):e14420. doi: 10.1002/alz.14420. Epub 2024 Dec 30.
6
Pilot: Salivary Lactoferrin as a Biomarker of Alzheimer's Disease.试点研究:唾液乳铁蛋白作为阿尔茨海默病的生物标志物
medRxiv. 2024 Nov 23:2024.11.22.24317405. doi: 10.1101/2024.11.22.24317405.
7
Salivary biomarkers: The early diagnosis of Alzheimer's disease.唾液生物标志物:阿尔茨海默病的早期诊断
Aging Med (Milton). 2024 Feb 20;7(2):202-213. doi: 10.1002/agm2.12282. eCollection 2024 Apr.
8
Salivary Biomarkers for Alzheimer's Disease: A Systematic Review with Meta-Analysis.用于阿尔茨海默病的唾液生物标志物:系统评价与荟萃分析。
Int J Mol Sci. 2024 Jan 18;25(2):1168. doi: 10.3390/ijms25021168.
9
Saliva: a challenging human fluid to diagnose brain disorders with a focus on Alzheimer's disease.唾液:一种用于诊断脑部疾病(尤其是阿尔茨海默病)颇具挑战性的人体液体。
Neural Regen Res. 2023 Dec;18(12):2606-2610. doi: 10.4103/1673-5374.373675.
10
The role of microbiome-host interactions in the development of Alzheimer´s disease.微生物组-宿主相互作用在阿尔茨海默病发展中的作用。
Front Cell Infect Microbiol. 2023 Jun 2;13:1151021. doi: 10.3389/fcimb.2023.1151021. eCollection 2023.